Search

Search Constraints

You searched for: Author/Creator Maher, Toby

Search Results

4. FRI0301 GASTROINTESTINAL ADVERSE EVENTS IN PATIENTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE (SSC-ILD) TREATED WITH NINTEDANIB: DATA FROM THE SENSCIS TRIAL. (June 2019)

8. Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study. Issue 9 (September 2019)

9. Systemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive disease. (29th September 2022)

10. Development of a Consensus Statement for the Definition, Diagnosis, and Treatment of Acute Exacerbations of Idiopathic Pulmonary Fibrosis Using the Delphi Technique. Issue 10 (October 2015)